| |
| |
|
| Insider
Information: |
Andreotti Lamberto |
| Relationship: |
|
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,011,868 |
|
|
Indirect Shares
|
241,273 |
|
|
| Direct
Value |
$40,817,011 |
|
|
|
Indirect Value
|
$9,863,240 |
|
|
| Total
Shares |
1,253,141 |
|
|
| Total
Value |
$50,680,251 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 14.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
Director |
2017-04-07 |
935,571 |
2017-04-07 |
241,273 |
Premium* |
|
|
Mead Johnson Nutrition Co |
MJN |
Director |
2009-12-23 |
19,609 |
2009-02-17 |
0 |
Premium* |
|
|
DuPont de Nemours Inc |
DD |
Director |
2017-08-31 |
0 |
2012-08-02 |
0 |
Premium* |
|
|
Dowdupont Inc. |
DWDP |
Director |
2019-05-21 |
22,231 |
|
0 |
Premium* |
|
|
Corteva, Inc. |
CTVA |
|
2024-04-26 |
34,457 |
2019-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
218 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DD |
DuPont de Nemours Inc |
Director |
– • – |
2015-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,880 |
8,888 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,893 |
280,128 |
0 |
- |
|
| DD |
DuPont de Nemours Inc |
Director |
– • – |
2017-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,920 |
14,186 |
0 |
- |
|
| DD |
DuPont de Nemours Inc |
Director |
– • – |
2014-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,940 |
6,826 |
0 |
- |
|
| DD |
DuPont de Nemours Inc |
Director |
– • – |
2012-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,210 |
2,210 |
0 |
- |
|
| DD |
DuPont de Nemours Inc |
Director |
– • – |
2016-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,230 |
12,011 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
officerTitle |
• – – |
2007-03-02 |
4 |
D |
$26.42 |
$59,921 |
D/D |
(2,268) |
254,751 |
0 |
- |
|
| DD |
DuPont de Nemours Inc |
Director |
– • – |
2013-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,470 |
4,740 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
• – – |
2007-03-06 |
4 |
D |
$27.01 |
$67,930 |
D/D |
(2,515) |
257,497 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
• – – |
2007-03-06 |
4/A |
D |
$27.01 |
$67,930 |
D/D |
(2,515) |
257,497 |
0 |
- |
|
| DWDP |
Dowdupont Inc. |
Director |
– • – |
2018-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,680 |
21,416 |
0 |
- |
|
| CTVA |
Corteva, Inc. |
Director |
– • – |
2023-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,770 |
31,021 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
• – – |
2008-03-02 |
4 |
D |
$22.61 |
$64,235 |
D/D |
(2,841) |
242,639 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Operating Officer |
• – – |
2009-03-02 |
4 |
D |
$17.74 |
$50,399 |
D/D |
(2,841) |
243,663 |
0 |
- |
|
| CTVA |
Corteva, Inc. |
Director |
– • – |
2022-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,950 |
27,968 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
• – – |
2008-03-01 |
4 |
D |
$22.61 |
$66,903 |
D/D |
(2,959) |
245,480 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Operating Officer |
• – – |
2009-03-01 |
4 |
D |
$18.41 |
$54,475 |
D/D |
(2,959) |
246,504 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2013-03-04 |
4 |
D |
$36.94 |
$113,517 |
D/D |
(3,073) |
409,451 |
0 |
- |
|
| CTVA |
Corteva, Inc. |
|
– • – |
2024-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,100 |
34,457 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres, COO & CEO Designate |
• • – |
2010-03-06 |
4 |
D |
$24.60 |
$76,875 |
D/D |
(3,125) |
220,171 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-03-06 |
4 |
D |
$26.43 |
$88,065 |
D/D |
(3,332) |
268,890 |
0 |
- |
|
| CTVA |
Corteva, Inc. |
Director |
– • – |
2021-05-07 |
4 |
A |
$48.86 |
$170,033 |
D/D |
3,480 |
24,726 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-03-04 |
4 |
D |
$26.43 |
$99,430 |
D/D |
(3,762) |
265,622 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2012-03-04 |
4 |
D |
$32.59 |
$122,604 |
D/D |
(3,762) |
315,733 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2013-03-03 |
4 |
D |
$37.15 |
$158,408 |
D/D |
(4,264) |
405,071 |
0 |
- |
|
218 Records found
|
|
Page 3 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
